We bring innovative therapies
The pathway to market treatment for rare diseases and unmet medical needs in Asia.
Our strategic Business model developed in collaboration with our partner DKSH allows to combine strengths to serve you better. Each company focuses on its core competences.
AxxessBio develops medical communication to Healthcare professionals, sources funding to help patients access to your innovative treatment in very early stages (pre-local marketing approval), develops relation with patient groups and government bodies to secure long term sustainable funding and promotes your product with a highly specialized sales team.
Our partner DKSH manages all necessary import documentations to bring your product on named patient basis and obtains the product registration, secures importation, storage and delivery to the end-users, invoices and collects payment.